Significantly, a role of TBX2 in oncogenic EMT and malignant breast cancer progression is further suggested by our finding that TBX2 mRNA levels in clinical human breast cancer specimen were highest in rare EMT-enriched tumors of the ‘claudin-low’ and metaplastic breast tumor subtypes. Here, TBX2 is linked to breast neoplasm.